Go Mediaction

Main Menu

  • Home
  • Medical field
  • Prescription drugs
  • Drug discovery
  • Medical diagnosis

Go Mediaction

Header Banner

Go Mediaction

  • Home
  • Medical field
  • Prescription drugs
  • Drug discovery
  • Medical diagnosis
Prescription drugs
Home›Prescription drugs›10 prescription drugs that cost Medicare the most

10 prescription drugs that cost Medicare the most

By Deborah A. Gray
March 8, 2022
0
0


“You certainly envision a significant impact on Medicare Part D spending, both on the program and on beneficiaries,” says Leigh Purvis, AARP’s director of healthcare cost and access. “It’s indicative of the larger problem where we’ve left pharma companies free to continue to engage in the kind of pricing behavior that has been problematic for so long.” New data from AARP shows that in January 2022, the average list price increase for the top 75 brand name drugs was 5.2%. Price increases ranged from 2% to 7.9%, and the prices of more than half (42 of 75) increased by 5% or more.As

AARP’s Fair Rx Prices Now campaign has worked to convince lawmakers to allow Medicare to negotiate prices with pharmaceutical manufacturers, impose tax penalties on drug manufacturers who raise prices more than the inflation and to cap Part D disbursements.

Here’s a look at the 10 drugs Medicare spent the most money on in 2020 and whose prices rose in January 2022.

1. Equip

  • Use: A blood thinner for people with atrial fibrillation (A-fib)
  • Health insurance expenditure in 2020: $9.9 billion
  • Number of beneficiaries: 2,641,941
  • January 2022 price increase: 6 percent

2. Revlimid

  • Use: To treat cancer
  • Health insurance expenditure in 2020: $5.4 billion
  • Number of beneficiaries: 43,747
  • January 2022 price increase: 4.5%

3. Xarelto

  • Use: A blood thinner for people with atrial fibrillation (A-fib)
  • Health insurance expenditure in 2020: $4.7 billion
  • Number of beneficiaries: 1,184,718
  • January 2022 price increase: 4.9%

4. Januvia

  • Use: To treat diabetes
  • Health insurance expenditure in 2020: $3.9 billion
  • Number of beneficiaries: 934 686
  • January 2022 price increase: 5 percent

5. Truth

  • Use: To treat diabetes
  • Health insurance expenditure in 2020: $3.3 billion
  • Number of beneficiaries: 497 327
  • January 2022 price increase: 5 percent

6. Imbruvic

  • Use: To treat cancer
  • Health insurance expenditure in 2020: $3 billion
  • Number of beneficiaries: 26,847
  • January 2022 price increase: 7.4%

7. Gardening

  • Use: To treat diabetes
  • Health insurance expenditure in 2020: $2.4 billion
  • Number of beneficiaries: 594 859
  • January 2022 price increase: 4 percent

8. Humira Pen (Cf)

  • Use: To treat rheumatoid arthritis, plaque psoriasis
  • Health insurance expenditure in 2020: $2.2 billion
  • Number of beneficiaries: 42,406
  • January 2022 price increase: 7.4%

9. Ibrance

  • Use: To treat cancer
  • Health insurance expenditure in 2020: $2.1 billion
  • Number of beneficiaries: 21,394
  • January 2022 price increase: 6.9%

10. Symbicort

  • Use: To treat asthma
  • Health insurance expenditure in 2020: $2 billion
  • Number of beneficiaries: 1,017,530
  • January 2022 price increase: 2 percent

Dena Bunis covers Medicare, health care, health policy and Congress. She also writes the “Medicare Made Easy” column for the AARP Newsletter. An award-winning journalist, Bunis has spent decades working for metropolitan dailies, including as Washington bureau chief for the Orange County Register and as a health and workplace policy maker for press day.

Categories

  • Drug discovery
  • Medical diagnosis
  • Medical field
  • Prescription drugs

Recent Posts

  • Drug Discovery Informatics Market growth opportunities to be exploited
  • key vendors, trends, analysis, segmentation, forecast to 2029 – Designer Women
  • Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com
  • PROBE AND ACT ON PRESCRIPTION DRUGS ABUSE
  • Prescription Drug Consumption Market Size, Share and Forecast to 2028 | Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD) – Designer Women

Archives

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • November 2020
  • September 2020
  • May 2020
  • March 2020
  • September 2019
  • May 2019
  • August 2018
  • December 2013
  • Privacy Policy
  • Terms and Conditions